Diabetes

University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments

University of Utah Enzyme Discovery Enables Programmable Peptide Modifications for Next-Generation Diabetes and Obesity Treatments

University of Utah researchers have developed an enzyme technology that can stabilize and enhance therapeutic peptides for diabetes and obesity treatments, with the innovation now advancing toward clinical development through spinout company Sethera Therapeutics.

October 14, 2025
Study Links Inflammation Markers in Diabetics to Depression Treatment Efficacy

Study Links Inflammation Markers in Diabetics to Depression Treatment Efficacy

A recent study reveals that inflammation markers in diabetics significantly affect the outcomes of depression treatments, highlighting the need for targeted therapeutic approaches.

August 5, 2025